Benzinga | Aug 11, 2020 04:07PM EDT

Health Catalyst Q2 Adj. EPS $(0.15) Beats $(0.22) Estimate, Sales $43.26M Beat $42.14M Estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.22) by 31.82 percent. This is a 28.57 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $43.26 million which beat the analyst consensus estimate of $42.14 million by 2.66 percent. This is a 17.54 percent increase over sales of $36.80 million the same period last year.